ALT Altimmune, Inc. Common Stock PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

Altimmune (ALT) Stock: Buy, Sell, or Hold?

$1.93
-0.01 (-0.52%) ▼
5d: -8.96% 30d: -20.58% 90d: -32.99%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (58%)
Quality Score
48/100
Position
OVERSOLD
30-Day Fair Range
$2.00 – $2.47
Position: OVERSOLD
Forward P/E & Valuation
-2.9x
Next 12M consensus est.
Wall Street Target
$17.11
+786.6% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.90 / $2.21
Trend: Strong Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: ALT shows conflicting indicators. Wait for confirmation before entering.

Get Alerted When ALT Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: ALT is currently trading at $1.93, which is considered oversold relative to its 30-day fair value range of $2.00 to $2.47.

Technical Outlook: Technically, ALT is in a strong downtrend. The price is currently testing key support at $1.90. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: ALT scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $17.11 (+786.6%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $2.00 - $2.47
Company Quality Score 48/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 57.9%

Trading Range & Key Levels

30-Day Trading Range $2.00 - $2.47
Current vs Trading Range OVERSOLD
Support Level $1.90
Resistance Level $2.21
Current Trend Strong Downtrend
Technical data as of Nov 11, 2026

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • BEARISH: Weak technical setup (33/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 786.6% below Wall St target ($17.11)
  • WARNING: Composite score 48/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -2.89
Wall Street Target $17.11 (+786.6%)
Revenue Growth (YoY) 420.0%
Share ALT Analysis

Share this live ALT analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (ALT)

Bullish 8 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
7 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary: StockTwits messages are predominantly bullish, with traders expressing optimism about $ALT following robust discussions in quarterly reports and potential partnerships.
Key Retail Themes: Company's potential partnerships Positive quarterly reports
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 7:00 AM ET
Data refreshes hourly during market hours. Next update: 8:00 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for ALT.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BMRN
Biomarin Pharmaceutical …
STRONG BUY
28 analysts
$91 56 HOLD
AXSM
Axsome Therapeutics Inc
STRONG BUY
22 analysts
$266 55 HOLD
DNLI
Denali Therapeutics Inc
STRONG BUY
20 analysts
$36 49 HOLD
INCY
Incyte Corporation
HOLD
28 analysts
$132 52 HOLD
BBIO
BridgeBio Pharma Inc
STRONG BUY
22 analysts
$107 33 SELL

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive ALT Research Pages
ALT Technical Chart ALT Price Prediction ALT Intrinsic Value DCF ALT Earnings Date ALT Investment Advisor ALT Fair Price Analyzer ALT Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals